| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8964157 | Archives of Medical Research | 2018 | 8 Pages |
Abstract
The results show that high plasma copeptin levels are associated with the decline of renal function in patients with T2DM and, therefore, copeptin may be considered as a biomarker of renal function. Further evaluation of plasma copeptin levels to predict morbidity and mortality of T2DM patients, with or without CKD, has been taken into our consideration.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Maria De La Luz Villela-Torres, Ana Edith Higareda-Mendoza, Anel Gómez-GarcÃa, Alfonso Rafael Alvarez-Paredes, Elvia GarcÃa-López, Peter Stenvikel, Harvest F. Gu, Abbul Rashid-Qureshi, Bengt Lindholm, Cleto Alvarez-Aguilar,